-
How a scrapped Pfizer drug became a winner for SpringWorks
21 Apr 2025 12:44 GMT
… Despite promising early data, Pfizer shelved mirdametinib when it became … pursuing.
She was right. Pfizer spun out SpringWorks Therapeutics to … away their asset’s patent life while waiting for … the body.
Bakker convinced Pfizer that mirdametinib not only had …
-
A Pharmacist’s Guide to Blockbuster Patent Expirations: 2025 and Beyond
18 Apr 2025 18:06 GMT
… offsetting revenue lost after the patent expiration of rosuvastatin (Crestor; … 2025. The solid oral formulation patent, including pediatric exclusivity, is … Pfizer), another leading DOAC, has a more complex patent landscape. Although certain patents …
-
Roche's HEMLIBRA Achieves Significant Uptake Across Key Hemophilia A Markets | DelveInsight
21 Apr 2025 23:51 GMT
… The report provides product descriptions, patent details, and competitor products … Therapeutics]), fitusiran (Sanofi), marstacimab (Pfizer), Mim8 (Novo Nordisk), and … Sanofi (Genzyme), Alnylam Pharmaceuticals, Pfizer, Sangamo Therapeutics, Bayer, Ultragenyx …
-
Can anything threaten Novo and Lilly’s obesity market dominance?
21 Apr 2025 12:44 GMT
… company has filed 320 patent applications for its three … through a Patent Term Adjustment and a Patent Term Extension, … build [those patents] up over time.”
These patent strategies have … as Viking Therapeutics and Pfizer moving candidates through the …
-
Vaccinex to Report Promising New Clinical Data Revealing Pepinemab’s Unique Mechanism to Enhance Immunotherapy at Annual Meeting of American Association for Cancer Research (AACR)
21 Apr 2025 12:45 GMT
… .gov. KEYTRUDA is a registered trademark of Merck Sharp & Dohme … Merck KGaA, Darmstadt, Germany and Pfizer. Forward Looking Statements
To the …
-
Older adults respond well to immunotherapy despite age-related immune system differences
21 Apr 2025 11:58 GMT
… KGaA, Natera, Nektar, Novartis, OncoSec, Pfizer, Rain Therapeutics, Regeneron, Replimune, Sanofi … to that license. Ho reports patent royalties from Rodeo/Amgen …
-
Donald Trump's tariffs could backfire and any bitter pill for pharma can benefit UK, says RUTH SUNDERLAND
20 Apr 2025 21:16 GMT
… such as Eli Lilly and Pfizer.
It is not clear yet … lowest for makers of off-patent generic drugs, many of them …
-
3 Ultra-High-Yield Dividend Stocks to Buy Right Now That Are Dirt Cheap
20 Apr 2025 11:38 GMT
… -based escalation provisions.
3. Pfizer
Pfizer's (PFE 0. … patent cliff for several of its top products, and Pfizer … late-stage clinical development.
Pfizer recently announced its 16th … Enterprise Products Partners, and Pfizer. The Motley Fool has …
-
Meet the AgriBusiness Global Visionary Leaders for 2025 (Part 2)
19 Apr 2025 12:03 GMT
… BASF, Monsanto, DuPont, Bayer, and Pfizer, we built credibility and expanded … PI Industries toward high-value, patented molecules, avoiding commodity-based business … to have an indigenously developed patented molecule for the global market …
-
Pharmaceutical Compounding Calculations, Part One–Non-Salts, Salts, and Policy-Exception Salts
18 Apr 2025 19:05 GMT
… Compositions Having Good Stability. US patent 5180589A, 1991. https:/… ;patents.google.com/patent/;US5180589A/en … , Inc. https://labeling.pfizer.com/ShowLabeling.aspx?id= …
About
© 1995-2025